Histopathological regression of systemic AA amyloidosis after surgical treatment of a localized Castleman's disease
Authors:
- Yo-Ichi TakeiYTYo-Ichi Takei
- Ko-Ichi TazawaKTKo-Ichi Tazawa
- Takahisa GonoTGTakahisa Gono
- Tomohisa FushimiTFTomohisa Fushimi
- Masayuki MatsudaMMMasayuki Matsuda
- Yoshinobu HoshiiYHYoshinobu Hoshii
- Shu-Ichi IkedaSIShu-Ichi Ikeda
- 1 January 2006
- journal article
- case report
- Published by Taylor & Francis in Amyloid
- Vol. 13 (3) , 184-186
Abstract
Previously, we reported a case of localized plasma cell type Castleman's disease with severe hepatomegaly and reactive systemic AA amyloidosis. The amyloid deposits were demonstrated in both the hepatic tissue and in the gastric mucosa. Surgical resection of an isolated extra-hepatic tumor was performed. The laboratory findings, including SAA and IL-6, remained within normal limits and the patient's hepatomegaly subsequently showed regression. Nine years after the operation, no amyloid deposition was seen in the gastric mucosa and the patient's liver was of normal size. Our findings with long-term follow up in this case indicated that the cessation of SAA production was the probable cause of histopathological regression of AA amyloid deposits in this patient.Keywords
This publication has 7 references indexed in Scilit:
- IL-6 plays a critical role in the synergistic induction of human serum amyloid A (SAA) gene when stimulated with proinflammatory cytokines as analyzed with an SAA isoform real-time quantitative RT-PCR assay systemBiochemical and Biophysical Research Communications, 2004
- Unicentric Castleman's disease complicated by systemic AA amyloidosis: a curable diseaseQJM: An International Journal of Medicine, 2002
- Systemic reactive amyloidosis associated with Castleman's disease: serial changes of the concentrations of acute phase serum amyloid A and interleukin 6 in serum.Journal of Clinical Pathology, 1997
- Regression of Nephrotic Syndrome with Colchicine Therapy Secondary to Amyloidosis with Associated Castleman’s DiseaseNephron, 1995
- Reversal of nephrotic syndrome due to reactive amyloidosis (AA‐type) after excision of localized Castleman's diseaseAmerican Journal of Hematology, 1994
- Interleukin-6 gene expression in Castleman's diseaseBlood, 1991
- Ultrastructural evidence for intracellular formation of amyloid fibrils in macrophagesVirchows Archiv, 1989